Acorda Therapeutics Inc., the Ardsley-based biotechnology company, recently received two silver awards at the annual Medical Marketing & Media (MM&M) Awards ceremony.
The company was honored for its AMPYRA.com consumer site in the category of best branded website and for its AMPYRA healthcare professional campaign in the best professional print campaign category. AMPYRA is approved by the U.S. Food and Drug Administration as a treatment to improve walking in patients with multiple sclerosis.
The MM&M Awards recognize exceptional creativity and marketing effectiveness among all companies in the pharmaceutical and biotechnology industries. Only two awards are given in each of 24 categories. More than 100 independent industry judges scored this year”™s rounds of competition.
Lauren Sabella, Acorda”™s executive vice president of commercial development, in a statement said the company”™s goal with its consumer website and professional campaign “is to increase awareness of important information about MS and AMPYRA, helping to facilitate educated dialogue between physicians and consumers about their healthcare decisions.”
Acorda this year also was awarded the PM360 Trailblazer Award for best health care professional advertising campaign and picked up gold and silver awards from the International Academy of the Visual Arts for its AMPYRA.com site. The company also received two Telly Awards this year for online video production and editing.
